David Schaaf
Chief Tech/Sci/R&D Officer at PDS BIOTECHNOLOGY CORPORATION
Profile
David Schaaf is currently the Vice President-Medical Affairs at PDS Biotechnology Corp.
He previously worked as the Vice President-Medical Affairs at Zogenix, Inc. Schaaf has a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Stanford University.
David Schaaf active positions
| Companies | Position | Start |
|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Chief Tech/Sci/R&D Officer | 01/09/2022 |
Former positions of David Schaaf
| Companies | Position | End |
|---|---|---|
| ZOGENIX, INC. | Chief Tech/Sci/R&D Officer | - |
Training of David Schaaf
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Stanford University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
- Stock Market
- Insiders
- David Schaaf
